|
|
||||||||
1 Equine Research Centre, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa
2 Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa
Correspondence
Melvyn Quan
melvyn.quan{at}up.ac.za
| ABSTRACT |
|---|
|
|
|---|
, β and
). Some serotypes (6, 8 and 9 in
; 3 and 7 in β; 2 in
) were restricted to a single clade, while other serotypes (1, 4 and 5) clustered into both the
and
clades. Strong purifying selection was evident and a constant molecular clock was inappropriate. The S10 gene is the second most variable gene of the AHSV genome and the use of S10 in molecular epidemiology was illustrated by an AHS outbreak in the Western Cape in 2004. It was shown that two separate AHSV were circulating in the area, even though AHSV serotype 1 was the only isolate from the outbreak. The small size of the gene (755–764 bp) and conserved terminal regions facilitate easy and quick sequencing. The establishment of an S10 sequence database is important for characterizing outbreaks of AHS. It will be an essential resource for elucidating the epidemiology of AHS. The GenBank/EMBL/DDBJ sequence accession numbers for the sequences reported in this study are EU433402–EU433555.
Supplementary material is available with the online version of this paper.
| INTRODUCTION |
|---|
|
|
|---|
AHSV is a member of the genus Orbivirus, the family Reoviridae of which Bluetongue virus (BTV) is the type species. The virus consists of 10 segments of double-stranded RNA that encodes seven structural proteins (VP1–VP7) and four non-structural proteins (NS1, NS2, NS3 and NS3a). The genome is surrounded by an inner capsid, which forms the virus core and has two distinct layers of proteins. The inner layer or subcore is composed of VP3 and associated with it are three minor structural proteins (the core-associated enzymes VP1, VP4 and VP6). The outer surface of the core particle is composed of VP7. Surrounding the inner capsid is the outer capsid composed of VP2 and VP5 proteins. VP2 contains the major serotype-specific, neutralizing antigens and is primarily involved in cell attachment and penetration (Stone-Marschat et al., 1996
; Burrage et al., 1993
).
The RNA small segment 10 (S10) gene is the smallest segment of the AHSV genome, between 755 and 764 bp long. It contains two overlapping in-phase open reading frames that encode two non-structural proteins, NS3 and NS3a (van Staden & Huismans, 1991
; Mertens et al., 1984
). NS3 is larger than NS3a as a result of an additional 10 aa at the N-terminal end. NS3 is an integral membrane protein (Bansal et al., 1998
; Wu et al., 1992
; Hyatt et al., 1991
) and it has been suggested that the protein is involved in the final stages of viral morphogenesis and release of virions (Wirblich et al., 2006
; Martin et al., 1998
; Stoltz et al., 1996
; Hyatt et al., 1993
). It is cytotoxic to in vitro insect cells (van Niekerk et al., 2001a; van Staden et al., 1995
) and it may play a role in the determination of virulence (O'Hara et al., 1998
).
NS3 is the second most variable AHSV protein after the outer capsid protein VP2, and it can vary 37 % across serotypes and 28 % within serotypes (van Niekerk et al., 2001b
). The AHSV NS3 is not as well conserved as the BTV NS3, which varies by only 7–10 % (van Niekerk et al., 2001b
) and the equine encephalosis virus (EEV) NS3, which varies by 17 % (van Niekerk et al., 2003
). Conserved regions within AHSV NS3 have been reported to be (i) the initiation codon for NS3a, (ii) a proline-rich area between residues 22 and 34, (iii) a sequence of highly conserved amino acids from residues 46 to 90 and (iv) two hydrophobic regions (residues 116–137 and 154–170, respectively) predicted to form transmembrane helices (van Staden et al., 1995
).
Between 2004 and 2006, 145 AHSV were isolated from blood and organ samples submitted from South Africa, Namibia and Zimbabwe to the Department of Veterinary Tropical Diseases (DVTD), Faculty of Veterinary Science, University of Pretoria. The S10 nucleotide sequences of these isolates were determined and the phylogeny of S10 was investigated, first by comparing AHSV S10 to other orbivirus S10 genes and then by determining the relationship of all AHSV S10 sequences to each other, the three distinct phylogenetic clades (
, β and
) of AHSV S10 described previously (van Niekerk et al., 2003
; Martin et al., 1998
; Sailleau et al., 1997
), the established nine AHSV serotypes (Coetzer & Guthrie, 2004
) and the geographical location where they were isolated. The phylogeny of AHSV S10 has never been described using the number of isolates indicated in this paper.
Another novel aspect of this study was the use of the S10 data to characterize AHS outbreaks. The high sequence variation in S10 makes the identification of various AHSV variants possible. An AHS outbreak in 2004 in the Western Cape, a region usually free of the disease, was examined, as good epidemiological data and field samples were available (Sinclair, 2006
). Linking epidemiological and sequence data are described and we examine whether the molecular data provide additional information to the epidemiology of the outbreak.
| METHODS |
|---|
|
|
|---|
Approximately 5 g (1.5x1.5x1.5 cm) of spleen or lung tissue was selected and ground to a fine paste by using sterile sand and a pestle and mortar. Ten millilitres of Dulbecco's phosphate-buffered saline with gentamicin (to a final concentration of 0.1 mg ml–1; Virbac) was added to the macerated tissue and the suspension was transferred to a 20 ml sterile MacCartney bottle. The mixture was centrifuged at 440 g for 10–15 min, two cryovials of unfiltered supernatant were stored at –80 °C for future reference and the remainder was filtered through a 0.22 µm membrane filter (Microsep).
Processed blood (0.2 ml) or 0.5 ml organ sample filtrate was inoculated onto a confluent monolayer of BHK-21 cells in 25 cm2 tissue culture flasks. Cell cultures were incubated at 37 °C and observed daily for any cytopathic effects (CPE). Blood cells were washed off after 3 days and the medium replaced. Cultures showing no CPE after 10–14 days were passaged by inoculating 0.2–0.5 ml of the culture onto a freshly prepared BHK-21 cell monolayer. When 100 % of the cell monolayer showed CPE or had detached from the surface due to degeneration, the cells and supernatant were harvested and identified as AHSV by competitive ELISA (Hamblin et al., 1990
). Cultures showing no CPE after three passages were classified as negative for AHSV.
Plaque inhibition neutralization test.
The serotype of AHSV recovered from the sample was determined by a modified plaque inhibition test, after the technique described by Porterfield (1960)
, in which electrical insulating fish-spine beads filled with type-specific antiserum were used to indicate homologous virus–antibody neutralization. A set of three confluent monolayers of Vero cells prepared in 35 mm diameter cluster plates was inoculated with a dilution of the virus sample. After adsorption for 1 h at 37 °C in a 5 % CO2 gassed and humidified incubator, the inoculum was removed and replaced with 5 ml of an agarose overlay containing 1 : 20 000 neutral red. The fish-spine beads, containing the type-specific antisera, were placed in strict sequence on the surface of the overlay, after which the plates were returned to the incubator. Homologous neutralization was clearly evident around the periphery of a bead by the absence of plaques after 5–6 days incubation.
RNA extractions.
The contents of a tissue culture flask (
three passages) that showed an AHSV-positive ELISA were agitated and 1 ml transferred to a 1.5 ml Eppendorf tube. Samples were spun at 3000 r.p.m. for 10 min in a 5417C centrifuge (Eppendorf) and the supernatant was discarded. RNA extractions from the cell pellet were performed with either TRIzol (Invitrogen) or the RNeasy Mini kit (Qiagen) according to the manufacturer's instructions. RNA was dissolved in either 50 µl TE buffer (10 mM Tris, 1 mM EDTA, pH 7.0; Ambion) or 50 µl nuclease-free H2O (Ambion) and stored at –80 °C. To denature the RNA, 1 µl 0.2 M methylmercury (II) hydroxide (Alfa Aesar) was added to every 5 µl of thawed RNA. The mixture was incubated for 10 min at room temperature before reduction with 1 µl 1 M 2-mercaptoethanol (Sigma) per 5 µl RNA.
RT-PCR.
A one-step RT-PCR was performed with the GeneAmp Gold RNA PCR core kit (Applied Biosystems) according to the manufacturer's instructions. Two 25 µl reactions were performed per sample, containing 2 µl denatured RNA, 0.5 µl 20 nM MQ.AHS.NS3.1-22F (5'-GTTTAAATTATCCCTTGTCATG-3') and 0.5 µl 20 nM MQ.AHS.NS3.749-769R (5'-GTAAGTCGTTATCCCGGCTC-3') terminal primers per reaction. Cycling conditions for RT-PCR were 42 °C for 12 min, 95 °C for 10 min; 40 cycles of 94 °C for 20 s, 57 °C for 30 s, 72 °C for 60 s and 72 °C for 7 min, and a hold at 4 °C on a GeneAmp PCR System 9700 (Applied Biosystems). Five microlitres PCR product mixed with 1 µl loading dye (Fermentas) was visualized by UV trans-illumination of a 1.5 % ethidium bromide stained agarose gel electrophoresed at 110 V.
The two RT-PCR reactions per sample were combined and the mixture cleaned up using a QIAquick PCR purification kit and a QiaVac 6S vacuum manifold (Qiagen) according to the manufacturer's instructions. Samples were eluted in 60 µl EB buffer (Qiagen).
Sequencing.
A BigDye Terminator v3.1 cycle sequencing kit was used for sequencing. At least two forward and two 1/4 (2 µl) reverse reactions (4–7 µl DNA, total volume per reaction=20 µl) were performed per sample according to the manufacturer's instructions. Cycling conditions and clean-up of sequencing products were as described in the Applied Biosystems protocol. Samples were analysed with an ABI 3130xl Genetic Analyzer (Applied Biosystems).
Phylogenetic analyses
Orbivirus phylogeny.
Orbivirus S10 sequence data were obtained from the GenBank website (http://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed). Protein sequences were aligned with MAFFT (v5.8) (Katoh et al., 2002
, 2005
) using the L-INS-i and MAFFT homologues options, then back-translated into nucleotide sequences by the tranalign programme in EMBOSS (Rice et al., 2000
).
A general time reversible model with a proportion of invariable sites and a gamma-shaped distribution of rates across sites (GTR+I+
) substitution model was determined by Modeltest v3.7 (Posada & Crandall, 1998
) and MrModeltest2 (Nylander, 2004
). PAUP* v4b10 (Swofford, 2003
) was used to explore distance, parsimony (using a heuristic search and tree bisection reconnection) and maximum-likelihood phylogenetic methods for both nucleotide and amino acid sequences; MRBAYES v3.1.1 (Ronquist & Huelsenbeck, 2003
; Huelsenbeck & Ronquist, 2001
) was used to explore Bayesian methods. The consensus tree was constructed in MEGA v4 (Tamura et al., 2007
; Kumar et al., 1994
).
Saturation was evaluated by plotting transitions and transversions against K80 distance using DAMBE (Xia & Xie, 2001
). The likelihood ratio test (Felsenstein, 1981
) was used to test the molecular clock using values obtained from Modeltest v3.7. The relative abundance of synonymous and non-synonymous substitutions within the S10 gene was calculated with the Nei–Gojobori method (Nei & Gojobori, 1986
) in MEGA v4, and the Z-test used to test for neutrality.
S10 phylogeny.
Phred (Ewing et al., 1998
; Ewing & Green, 1998
) and the Staden package (Staden et al., 2000
; Staden, 1996
) were used for base calling and sequence assembly. A sequence alignment was done with MAFFT using the G-INS-i option.
A cladogram was generated with MRBAYES v3.1.1 using a GTR+
substitution model (as determined by MrModeltest2) and three heated chains. The consensus tree was constructed in MEGA v4. Genetic distances were calculated between 56 AHSV isolates with unique S10 sequences, using a transversional model and a gamma-shaped distribution of rates across sites (TVM+
) substitution model (as determined using Modeltest v3.7) and PAUP* v4b10.
Conserved regions, hydropathicity and transmembrane domains of the AHSV NS3 were determined using the plotcon, pepwindowall (Kyte & Doolittle, 1982
) and tmap (Persson & Argos, 1994
) programmes within EMBOSS.
| RESULTS |
|---|
|
|
|---|
A maximum-parsimony cladogram based on amino acid sequences and a Bayesian phylogram based on nucleotide sequences are shown in Fig. 1
. Although there were differences between the trees, areas of agreement existed. AHSV formed a monophyletic group separate from other orbiviruses. The closest relation to AHSV appeared to be a group including BTV, although the support for this association was weak (bootstrap value of 58 %). The latter group was made up of BTV, which was closely related to epizootic hemorrhagic disease virus (EHDV), Ibaraki virus (IBAV) and only weakly linked to Chuzan virus (CHUV) of the Palyam group (in the protein analysis, CHUV was not part of this group). Peruvian horse virus (PHV) was closely related to Yunnan orbivirus, while the closest relation to Broadhaven virus (part of the Great Island virus group) was St Croix River virus. EEV formed a separate clade from other orbiviruses.
|
2=1301.13, d.f.=40, P<0.001). A codon-based Z-test that tested the relative abundance of synonymous and non-synonymous substitutions within the orbivirus S10 gene indicated that strong purifying selection was operating on this gene (P<0.001).
AHSV S10 phylogeny
One hundred and forty-five AHSV were isolated from samples submitted to the Faculty of Veterinary Science, University of Pretoria between 2004 and 2006 (Fig. 2
). All nine serotypes were represented, with a range of 3–60 isolates (and 2–15 isolates with unique sequences) per serotype. Most of the samples were submitted from the Gauteng Province (GP, 53 %), followed by the Kwazulu-Natal Province (KZ, 18 %) and then the Western Cape Province (WP, 14 %) but they did not represent the prevalence of disease. The majority of AHSV serotypes submitted from GP were either serotype 7 (42 %) or serotype 5 (22 %). Outbreaks of serotype 1 occurred in the WP in 2004 and serotype 7 in KZ in 2005, which account for the majority of serotypes submitted from those provinces.
|
, β and
) (Fig. 3
; 3 and 7 in β; 2 in
) were restricted to a single clade, while other serotypes (1, 4 and 5) clustered into both the
and
clades.
|
|
2=280.84, d.f.=152, P<0.001). Overall, a strong purifying selection was operating on the S10 gene (P<0.001) but a pairwise comparison identified pairs of isolates for which positive selection was evident (P<0.05) (Fig. 3
|
AHS outbreak, Western Cape, 2004
The index case was a horse at Elsenburg Agricultural Research Farm that died on the 31 January 2004 (Fig. 6
and Table 1
). No viral isolations were performed from the first two horses that died in the outbreak, as annual rye grass toxicity was diagnosed and AHS was not suspected. Three horses died subsequently (22–24 February 2004) and one horse was clinically ill from AHS (26 February 2004). AHSV serotype 1 was isolated from all the samples submitted. S10 characterization showed that all these isolates belonged to the
clade (underlined isolates, Fig. 3
).
|
|
clade and not the
clade. The
clade isolates were only 65 % similar to the
clade and introduction of AHS to these farms was, therefore, from a separate source compared with that from Elsenburg. AHSV isolated from the remainder of the outbreak samples all belonged to the
clade. No difference in virulence between the two viruses was observed. The outbreak resulted in the death of 17 horses, with the last death on the 28 March 2004 at Kalbaskraal. S10 characterization showed that in this outbreak there were at least two separate introductions of AHSV to the Western Cape.
Isolates from the
clade showed sequence variation within the S10 gene, which may have been useful for tracking the spread of the virus and determining a chain of infection if these mutations were acquired during the course of the outbreak. The data showed that this was not the case and that a set of quasispecies was present from the beginning of the outbreak. Quasispecies can be described as a population of viruses without a defined unique sequence structure, but rather as a weighted average of a large number of different individual sequences (Biebricher & Eigen, 2006
; Domingo et al., 1978
). Quasispecies
i,
ii and
iii were all present at Troughend, Oakhill and Daktari farms at the beginning of the
clade outbreak and within 3 days of each other. In addition,
ii and
iii isolates were obtained from the same horse (Bow Street Belle, Table 1
), indicating quasispecies in one horse. Rather than a sequential acquisition of mutations during the outbreak, a genetically diverse population of viruses was present from the start of the outbreak and therefore no inference could be made about a chain of infection using the genetic data.
The source of the serotype 1 AHSV strains responsible for the Western Cape outbreak could not be determined. The paucity of samples at the onset of the seasonal occurrence of the disease in other regions, prior to the outbreak in the Western Cape did not identify the circulation of AHSV serotype 1 in the equine population. The closest related 2004 serotype 1 viruses to the Western Cape isolates, i.e. E25304
[GenBank]
, E29904
[GenBank]
and E26404
[GenBank]
(Fig. 3
) were all submitted to the DVTD after the occurrence of the Western Cape outbreak. Preceding the Western Cape outbreak in 2004, the AHS surveillance zone was free of AHS for 5 years. The last outbreak occurred in 1999 and was caused by AHSV serotype 7 (OIE, 1999; http://www.oie.int/eng/info/hebdo/a_info.htm). Subsequent to the 2004 outbreak, an outbreak of AHSV serotype 5 occurred in the AHS protection zone in 2006 (OIE, 2006; http://www.oie.int/eng/info/hebdo/a_info.htm).
| DISCUSSION |
|---|
|
|
|---|
One hundred and forty-five AHSV were isolated and sequenced from blood and organ samples submitted to our laboratory between 2004 and 2006. During that period, the virus collection was not representative of the AHS situation in the country, as samples submitted to the DVTD were biased towards those samples submitted from the formal equine sector, due to the costs involved in veterinary examinations and diagnostic tests. Very few samples were submitted from the Eastern Cape, yet it has one of the highest unvaccinated horse populations in the country (livestock values were obtained from the Department of Agriculture).
The phylogenetic analysis confirmed the presence of three distinct S10 phylogenetic clades (
, β and
), as previously reported (van Niekerk et al., 2003
; Martin et al., 1998
; Sailleau et al., 1997
). In our analysis, serotype 8 clustered only in the
clade. In contrast, van Niekerk et al. (2003)
found that serotype 8 clustered in both the
and β clades, while Martin et al. (1998)
found that it clustered in the
clade. Similar results were obtained when their data (GenBank accession nos AJ007307
[GenBank]
and AF276685
[GenBank]
) were included in our analyses (see Supplementary material available in JGV Online). With our data, the β clade was made up exclusively of serotypes 3 and 7.
Serotypes differed in the mean evolutionary distance of S10 within a serotype. Serotype 7 isolates showed very little variation in their S10 sequences. Although an AHS epidemic, caused by serotype 7, occurred in KZ in 2005, samples were also submitted from the NW, GP, KZ and EC. On the other hand, the S10 sequences from serotype 5 isolates were very diverse, appearing in the
and
clades and in different clusters within a clade. The differences in variation between serotypes may be a reflection of the disease characteristics at the time, an epidemic resulting in a viral population of fairly low genetic diversity, due to a rapidly replicating population under little selective pressure. On the other hand, endemic stability would favour a viral population of higher genetic diversity, due to a long period of selective pressure.
A large S10 distance within a serotype may be an indication of reassortment (exchange of segments of the AHSV segmented genomes between different AHSV infecting the same midge or horse). There are possible examples of reassortment, e.g. AHSV serotype 4 (Jane4) shares the identical S10 sequence to some of the serotype 1 isolates from the Western Cape (Fig. 3
).
Although strong purifying selection of the S10 gene was evident, there were isolates for which positive selection was detected. The positions of the amino acid changes of those isolates were plotted in Fig. 5
. They corresponded to hydrophilic regions that were not well conserved, suggesting that regions under selective pressure are extra/intracellular. The most variable region of the gene was between residues 139 and 158 and surrounded by two hydrophobic regions (van Staden et al., 1995
). Purifying or positive selection of the virus during cell culture amplification could not be accounted for, but the effect was minimized by sequencing the isolates obtained from three or fewer passages.
The use of molecular epidemiology of the S10 gene was illustrated with the AHS outbreak in the Western Cape in 2004, by showing that there were two separate AHSV circulating in the area. In contrast to the serotype 1
clade viruses, which shared the same S10 sequence, the serotype 1
clade isolates showed some genetic variation, which indicated a population of AHSV with differing genome sequences (quasispecies), rather than representing an accumulation of mutations over time. It was therefore not possible to identify a chain of infection for the outbreak in the Western Cape.
The significance of reassortment of field viruses with vaccine strains could not be established, as S10 sequence data of vaccine strains are unavailable. It is possible that the serotype 1
or
clade might represent a vaccine strain. Widespread vaccination is practised in the area with 70 % of horses vaccinated against AHSV (Sinclair, 2006
). In addition, concern was expressed that the closest related 2004 serotype 1
clade viruses (E25304
[GenBank]
and E29904
[GenBank]
) to the Western Cape isolates were as a result of vaccination, as both horses became ill 3 weeks after vaccination against AHSV. However, the S10 sequence from E25304
[GenBank]
and E29904
[GenBank]
was exactly the same as that obtained from Jane1, a documented virulent field strain. Likewise, the Jane4 sequence is exactly the same as the serotype 1
clade viruses from the Western Cape and is also virulent. The phylogeny suggests that none of the Western Cape isolates represents vaccine strains.
The S10 gene is the second most variable gene of the AHSV genome after VP2 and is therefore well suited for use in characterizing AHSV strains. In addition, the small size of the gene (755–764 bp) and conserved terminal regions facilitate easy and quick sequencing. It is not clear why there is such a large variation in the S10 gene. NS3 is membrane-associated and therefore may be under immunological pressure, unlike other AHSV non-structural proteins that are intracellular and much more conserved than NS3 (M. Quan, unpublished data).
The establishment of an S10 sequence database is important for characterizing outbreaks of AHS. The sequence data of the AHSV vaccine strains represent a gap in the current S10 sequence database. In addition, it would be desirable to sequence VP2, or a portion thereof, and to combine those data in the phylogenetic analysis. The database will be an essential resource for elucidating the epidemiology of AHS, but needs to be backed up with a sensitive and accurate surveillance system and submission of samples for viral isolation and characterization.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Biebricher, C. K. & Eigen, M. (2006). What is a quasispecies? Curr Top Microbiol Immunol 299, 1–31.[Medline]
Burrage, T. G., Tevejo, R., Stone-Marschat, M. & Laegreid, W. W. (1993). Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2. Virology 196, 799–803.[CrossRef][Medline]
Coetzer, J. A. W. & Guthrie, A. J. (2004). African horse sickness. In Infectious Diseases of Livestock, 2nd edn, pp. 1231–1246. Edited by J. A. W. Coetzer & R. C. Tustin. Cape Town: Oxford University Press Southern Africa.
Domingo, E., Sabo, D., Taniguchi, T. & Weissmann, C. (1978). Nucleotide sequence heterogeneity of an RNA phage population. Cell 13, 735–744.[CrossRef][Medline]
DuToit, R. M. (1944). The transmission of blue-tongue and horse sickness by Culicoides. Onderstepoort J Vet Sci Anim Ind 19, 7–16.
Ewing, B. & Green, P. (1998). Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8, 186–194.
Ewing, B., Hillier, L., Wendl, M. C. & Green, P. (1998). Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8, 175–185.
Felsenstein, J. (1981). Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol 17, 368–376.[CrossRef][Medline]
Hamblin, C., Graham, S. D., Anderson, E. C. & Crowther, J. R. (1990). A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus. Epidemiol Infect 104, 303–312.[Medline]
Huelsenbeck, J. P. & Ronquist, F. (2001). MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17, 754–755.
Hyatt, A. D., Gould, A. R., Coupar, B. & Eaton, B. T. (1991). Localization of the non-structural protein NS3 in bluetongue virus-infected cells. J Gen Virol 72, 2263–2267.
Hyatt, A. D., Zhao, Y. & Roy, P. (1993). Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Virology 193, 592–603.[CrossRef][Medline]
Katoh, K., Misawa, K., Kuma, K. & Miyata, T. (2002). MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30, 3059–3066.
Katoh, K., Kuma, K., Toh, H. & Miyata, T. (2005). MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res 33, 511–518.
Kumar, S., Tamura, K. & Nei, M. (1994). MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers. Comput Appl Biosci 10, 189–191.
Kyte, J. & Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. J Mol Biol 157, 105–132.[CrossRef][Medline]
Martin, L. A., Meyer, A. J., O'Hara, R. S., Fu, H., Mellor, P. S., Knowles, N. J. & Mertens, P. P. (1998). Phylogenetic analysis of African horse sickness virus segment 10: sequence variation, virulence characteristics and cell exit. Arch Virol Suppl 14, 281–293.[Medline]
Mertens, P. P., Brown, F. & Sangar, D. V. (1984). Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology 135, 207–217.[CrossRef][Medline]
Nei, M. & Gojobori, T. (1986). Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3, 418–426.[Abstract]
Nylander, J. A. A. (2004). MrModeltest v2. Program distributed by the author.
O'Hara, R. S., Meyer, A. J., Burroughs, J. N., Pullen, L., Martin, L. A. & Mertens, P. P. (1998). Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8. Arch Virol Suppl 14, 259–279.[Medline]
Persson, B. & Argos, P. (1994). Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 237, 182–192.[CrossRef][Medline]
Porterfield, J. S. (1960). A simple plaque-inhibition test for the study of arthropod-borne viruses. Bull World Health Organ 22, 373–380.[Medline]
Posada, D. & Crandall, K. A. (1998). Modeltest: testing the model of DNA substitution. Bioinformatics 14, 817–818.
Purse, B. V., Mellor, P. S., Rogers, D. J., Samuel, A. R., Mertens, P. P. & Baylis, M. (2005). Climate change and the recent emergence of bluetongue in Europe. Nat Rev Microbiol 3, 171–181.[CrossRef][Medline]
Rice, P., Longden, I. & Bleasby, A. (2000). EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16, 276–277.[CrossRef][Medline]
Ronquist, F. & Huelsenbeck, J. P. (2003). MRBAYES3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19, 1572–1574.
Sailleau, C., Moulay, S. & Zientara, S. (1997). Nucleotide sequence comparison of the segments S10 of the nine African horsesickness virus serotypes. Arch Virol 142, 965–978.[CrossRef][Medline]
Sinclair, M. (2006). The epidemiology of an African horse sickness outbreak in the Western Cape Province of South Africa in 2004. MSc thesis. University of Pretoria.
Staden, R. (1996). The Staden sequence analysis package. Mol Biotechnol 5, 233–241.[Medline]
Staden, R., Beal, K. F. & Bonfield, J. K. (2000). The Staden package, 1998. Methods Mol Biol 132, 115–130.[Medline]
Stoltz, M. A., van der Merwe, C. F., Coetzee, J. & Huismans, H. (1996). Subcellular localization of the nonstructural protein NS3 of African horsesickness virus. Onderstepoort J Vet Res 63, 57–61.[Medline]
Stone-Marschat, M. A., Moss, S. R., Burrage, T. G., Barber, M. L., Roy, P. & Laegreid, W. W. (1996). Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus type 4. Virology 220, 219–222.[CrossRef][Medline]
Swofford, D. L. (2003). PAUP*: Phylogenetic Analysis Using Parsimony (*and other methods), version 4b10. Sunderland, MA: Sinauer Associates.
Tamura, K., Dudley, J., Nei, M. & Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24, 1596–1599.
van Niekerk, M., Smit, C. C., Fick, W. C., van Staden, V. & Huismans, H. (2001a). Membrane association of African horsesickness virus nonstructural protein NS3 determines its cytotoxicity. Virology 279, 499–508.[CrossRef][Medline]
van Niekerk, M., van Staden, V., Van Dijk, A. A. & Huismans, H. (2001b). Variation of African horsesickness virus nonstructural protein NS3 in southern Africa. J Gen Virol 82, 149–158.
van Niekerk, M., Freeman, M., Paweska, J. T., Howell, P. G., Guthrie, A. J., Potgieter, A. C., van Staden, V. & Huismans, H. (2003). Variation in the NS3 gene and protein in South African isolates of bluetongue and equine encephalosis viruses. J Gen Virol 84, 581–590.
van Staden, V. & Huismans, H. (1991). A comparison of the genes which encode non-structural protein NS3 of different orbiviruses. J Gen Virol 72, 1073–1079.
van Staden, V., Stoltz, M. A. & Huismans, H. (1995). Expression of nonstructural protein NS3 of African horsesickness virus (AHSV): evidence for a cytotoxic effect of NS3 in insect cells, and characterization of the gene products in AHSV infected Vero cells. Arch Virol 140, 289–306.[CrossRef][Medline]
Wirblich, C., Bhattacharya, B. & Roy, P. (2006). Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol 80, 460–473.
Wu, X., Chen, S. Y., Iwata, H., Compans, R. W. & Roy, P. (1992). Multiple glycoproteins synthesized by the smallest RNA segment (S10) of bluetongue virus. J Virol 66, 7104–7112.
Xia, X. & Xie, Z. (2001). DAMBE: software package for data analysis in molecular biology and evolution. J Hered 92, 371–373.
Received 5 October 2007;
accepted 8 January 2008.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |